spotlight-cover

Bibliography

Bibliography

Fowler J et al (2013) Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized double-blind, vehicle-controlled pivotal studies, JDD, 12(6): 650-656.

Del Rosso JQ (2012) Advances in understanding and managing rosacea: Part 1 & 2, J Clin Aesth Derm, 5(3):16-25, 26-36..

Powell FC (2005) Clinical practice: Rosacea, NEJM 352: 793-803.

Del Rosso JQ (2007) Recently approved systemic therapies for acne vulgaris and rosacea. Cutis. 80(2):113-20.

van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S (2007) Systematic review of rosacea treatments. J Am Acad Dermatol. 56(1):107-15.

Chamaillard M, Mortemousque B, Boralevi F, et al (2008) Cutaneous and ocular signs of childhood rosacea, Arch Dermatol,144:167-171

Del Rosso JQ, Baldwin H, Webster G et al (2008) American Acne & Rosacea Society medical management guidelines, J Drugs Dermatol 7(6): 531-533.

Webster GF (2009) Rosacea. Med Clin North Am. 2009 93(6):1183-94.

Odom R, Dahl M, Dover J, et al (2009) Standard management options for rosacea, part 2: options according to subtype, Cutis 84: 97-104.

Odom R, Dahl M, Dover J, et al (2009) Standard management options for rosacea, part 1: overwiev and broad spectrum of care, Cutis 84: 43-47.

Gallo R et al (2010) Rosacea treatments: what’s new and what’s on the horizon? Am J Clin Dermatol, 11(5): 299-303.

Aksoy B et al (2010) The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities, BJD, 163: 719-725.

Belkert FC et al (2012) Willingness to pay and quality of life in patients with rosacea, JEADV, 27: 734-738.

Fowler J et al (2012). Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies, BJD, 166:633-641.

Hsu CC et al (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker, JAAD, 67: 128-135.

Weinstock LB, Steinhoff M (2013) Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin, JAAD, 68:875-876.